Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Eledoisin Peptide (Highly Pure)

<strong>Eledoisin Peptide (Highly Pure)</strong>_x000D_ <strong>Catalog number:</strong> B2012312_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 1188.4 g/mol_x000D_ <strong>Supplied as:</strong> Lyophilized_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> Eledoisin_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Lippe C, Bellantuono V, Ardizzone C, Cassano G. Eledoisin and Kassinin, but not Enterokassinin, stimulate ion transport in frog skin Peptides. 2004 Nov;25(11):1971-5._x000D_ 2: Erspamer V, Erspamer GF. Pharmacological actions of eledoisin on extravascular smooth muscle Br J Pharmacol Chemother. 1962 Oct;19(2):337-54._x000D_ 3: FREGNAN GB, GLAESSER AH. ACTIVITY OF ELEDOISIN, OTHER POLYPEPTIDES AND ERGOMETRINE ON THE UTERUS IN SITU OF RABBIT AND OTHER ANIMAL SPECIES J Pharm Pharmacol. 1964 Nov;16:744-50._x000D_ 4: Katsoyannis P, Ginos JZ. Chemical synthesis of peptides Annu Rev Biochem. 1969;38:881-912._x000D_ 5: Ferreira SH, Vane JR. The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat Br J Pharmacol Chemother. 1967 Jun;30(2):417-24._x000D_ 6: Ferreira SH, Rocha e Silva M. Potentiation of bradykinin and eledoisin_ by BPF (bradykinin potentiating factor) from Bothrops jararaca venom Experientia. 1965 Jun 15;21(6):347-9._x000D_ 7: Bertaccini G. Active polypeptides of nonmammalian origin Pharmacol Rev. 1976 Jun;28(2):127-77._x000D_ 8: Jaeger W. [Treatment of a severe course of keratoconjunctivitis sicca with eledoisin] Klin Monbl Augenheilkd. 1988 Feb;192(2):163-6._x000D_ 9: Cascieri MA, Chicchi GG, Freidinger RM, Colton CD, Perlow DS, Williams B, Curtis NR, McKnight AT, Maguire JJ, Veber DF, et al. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin_ binding site Klin Monbl Augenheilkd. 1988 Feb;192(2):163-6. doi: 10.1055/s-2008-1050096._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/3929520">10: Mitsuma T, Nogimori T, Sun DH, Chaya M. Effects of eledoisin on thyrotrophin secretion in rats Acta Endocrinol (Copenh). 1985 Sep;110(1):90-4. </a>_x000D_ _x000D_ <strong>Products Related to Eledoisin Peptide (Highly Pure) can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>

Product Specifications

Short Description

Catalog Number: B2012312 (5 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

P27 / KIP1 (SX53G8), CF647 conjugate, 0.1mg/mL
BNC470669-500 1x 500 µL

P27 / KIP1 (SX53G8), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD106 / VCAM1 (1.4C3), CF594 conjugate, 0.1mg/mL
BNC940149-100 1x 100 µL

CD106 / VCAM1 (1.4C3), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD11a (Cris-3), CF594 conjugate, 0.1mg/mL
BNC940151-100 1x 100 µL

CD11a (Cris-3), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
FOXP3 (3G3), CF647 conjugate, 0.1mg/mL
BNC470645-500 1x 500 µL

FOXP3 (3G3), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Calretinin / Calbindin 2 (Mesothelioma Marker) (CALB2/2603), CF594 conjugate, 0.1mg/mL
BNC942603-500 1x 500 µL

Calretinin / Calbindin 2 (Mesothelioma Marker) (CALB2/2603), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
ARF1 (Golgi Apparatus Marker) (3F1), CF640R conjugate, 0.1mg/mL
BNC402029-500 1x 500 µL

ARF1 (Golgi Apparatus Marker) (3F1), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details